腹膜透析在合并腹水的肾衰竭患者中的应用:综述
该综述指出,合并腹水的肾衰竭患者因血流动力学不稳定、凝血病、营养不良和脑病等因素,血液透析耐受性差;观察性研究显示腹膜透析(PD)可提供血流动力学稳定性、改善容量管理、通过持续引流腹水避免治疗性穿刺、避免常规抗凝减少出血并发症,且腹膜炎和机械并发症与无腹水PD患者相当,不影响移植资格。因此PD应被视为合并腹水肾衰竭患者的可行透析选择。
要点
- 合并腹水的肾衰竭患者血液透析耐受性差,腹膜透析可提供血流动力学稳定。
- 腹膜透析通过持续引流腹水避免治疗性穿刺,并避免常规抗凝减少出血风险。
- 小样本研究提示腹膜透析的腹膜炎和机械并发症与无腹水患者相当。
核心结论
- 腹膜透析应被视为合并腹水的肾衰竭患者的可行透析选择。
研究设计与样本
- 综述,未报告系统检索范围与样本量。
主要发现
- 观察性研究显示腹膜透析相比血液透析提供血流动力学稳定性并促进更好的容量管理。
- 腹膜透析通过持续引流腹水避免治疗性穿刺。
- 腹膜透析避免常规抗凝从而可能减少出血并发症。
- 小样本研究提示腹膜透析患者的腹膜炎和机械并发症与无腹水腹膜透析患者相当。
- 腹膜透析不影响移植资格,患者可成功接受肝肾联合移植。
临床怎么用
- 对合并腹水的肾衰竭患者,应评估腹膜透析作为透析方式的可行性。
- 腹膜透析可用于需要避免治疗性穿刺和常规抗凝的腹水患者。
局限性
- 证据主要来自观察性研究和小样本研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The past few decades have seen steady increase in the prevalence of kidney failure needing kidney replacement therapy. Concomitantly, there has been progressive growth of heart failure and chronic liver disease, and many such patients develop ascites. Therefore, it is not uncommon to encounter patients with kidney failure who concurrently have ascites. The presence of ascites adds many challenges in the management of kidney failure. Poor hemodynamics make volume management difficult. The presence of coagulopathy, malnutrition, and encephalopathy compounds the complexity of the management. Such patients do not tolerate hemodialysis well. However, several concerns have limited the use of peritoneal dialysis (PD), so hemodialysis remains the predominant dialysis modality in these patients. However, observational studies have illustrated that PD provides hemodynamic stability and facilitates better volume management compared with hemodialysis. Moreover, PD obviates the need for therapeutic paracentesis by facilitating continuous drainage of ascites. PD potentially reduces hemorrhagic complications by avoiding routine anticoagulation use. Moreover, small studies have suggested that outcomes such as peritonitis and mechanical complications are comparable to those in PD patients without ascites. PD does not affect transplant candidacy, and these patients can successfully receive combined liver and kidney transplants. Hence, PD should be considered a viable dialysis option in kidney failure patients with ascites.
引用
- Rajora N, De Gregorio L, Saxena R, et al. Peritoneal Dialysis Use in Patients With Ascites: A Review. Am J Kidney Dis. 2021. PMID: 34144102. doi:10.1053/j.ajkd.2021.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。